Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A14NKG / Name: Invitae / Stock / Biotechnology & Medical Research / Mid Cap /
Your prediction

Invitae Corp Stock

For the coming years our community has positive and negative things to say abot the Invitae Corp stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.

Pros and Cons of Invitae Corp in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Invitae Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Invitae Corp - - - - - - -
Ironwood Pharmaceuticals 0.850% 0.000% -19.048% -38.342% -41.667% -41.089% -
Novocure Ltd 4.580% 11.578% 84.670% -71.506% 46.830% -85.900% -
Iovance Biotherapeutics Inc. -0.020% -4.136% -10.611% 39.612% 21.696% -35.884% -

Comments

Sell Invitae Corp
Show more

News

Is Invitae Stock a Buy Now?: https://g.foolcdn.com/editorial/images/762971/gettyimages-1072035598.jpg
Is Invitae Stock a Buy Now?

Invitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned through more and more cash, prompting it to